Sugi Predict

Sugi Predict / Compounds / SCHEMBL22248779

SCHEMBL22248779

SCHEMBL22248779

Clc1nc(-c2ccccc2)nc(-c2cccc3sc4ccc(-c5cccc6ccccc56)cc4c23)n1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.37
▸ ALDH1A1 P00352 2/20 0.37
▸ ATM Q13315 2/20 0.37
▸ HSD17B10 Q99714 2/20 0.37
▸ TP53 P04637 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ HPGD P15428 1/20 0.37
▸ TSHR P16473 1/20 0.37
▸ NFKB1 P19838 1/20 0.37
▸ MAPK1 P28482 1/20 0.37
▸ NFKB2 Q00653 1/20 0.37
▸ RELA Q04206 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ TDP1 Q9NUW8 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ MCL1 Q07820 1/20 0.35
▸ ACMSD Q8TDX5 1/20 0.35
▸ F9 P00740 1/20 0.35
▸ SERPINE1 P05121 1/20 0.35
▸ CYP1A2 P05177 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25132311 0.97 KDM4E (0.35) KDM4EALDH1A1ATMHSD17B10TP53
SCHEMBL26597950 0.93 KDM4E (0.40) KDM4EALDH1A1ATMHSD17B10TP53
SCHEMBL26598934 0.92 LIMK1 (0.35) KDM4EALDH1A1MAPTHPGDTSHR
SCHEMBL25132612 0.91 F9 (0.35) KDM4ETSHRF9ALOX5SLC9A1
SCHEMBL23975477 0.91 PIM3 (0.38) KDM4EALDH1A1MAPTHPGDTSHR
SCHEMBL25132264 0.91 PIM3 (0.38) KDM4EALDH1A1MAPTHPGDTSHR
SCHEMBL30203850 0.91 PIM3 (0.38) KDM4EALDH1A1MAPTHPGDTSHR
SCHEMBL22161528 0.89 S1PR5 (0.37) KDM4EALDH1A1HSD17B10TP53SMN1; SMN2
SCHEMBL19802567 0.89 F9 (0.36) KDM4EALDH1A1ATMHSD17B10TP53
SCHEMBL20871903 0.87 LIMK1 (0.36) KDM4EALDH1A1MAPTHPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11691966-B2 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2023-07-04 — — US disclosed
US-11691966-B2 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2023-07-04 — — US disclosed
US-20200231581-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2020-07-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11691966-B2 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof PIEZO1, OR51E2, OR10J3 KDM4E 757/4885ALDH1A1 502/4885ATM 4294/4885
US-20200231581-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF PIEZO1, OR51E2, OR10J3 KDM4E 757/4885ALDH1A1 502/4885ATM 4294/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.